Polymorphism of Apolipoprotein A5 is a Risk Factor for Cerebral Infarction in Type 2 Diabetes

Xuefeng Li,Yancheng Xu,Yan Ding,Chengming Qin,Zhe Dai,Li Niu

DOI: https://doi.org/10.1007/s11596-008-0608-5

2008-01-01

Abstract:This study investigated the association of apolipoprotein A5 (apoA5) gene polymorphism at position −1131T>C with cerebral infarction in patients with type 2 diabetes. A total of 256 type 2 diabetic patients without cerebral infarction (T2DM), 220 type 2 diabetic patients with cerebral infarction (T2DMCI) and 340 healthy subjects were recruited from the same region (Hubei province, China). The genotype of apoA5 −1131T〉C was analyzed by polymerase chain reaction, followed by restriction fragment length polymorphism (PCR-RFLP). Total cholesterol, HDL cholesterol, LDL-cholesterol and triglycerides were quantitatively detected by using standard enzymatic techniques. The results showed that the prevalence of the apoA5 −1131C allele was significantly higher in T2DMCI group than that in control group (42.7% versus 31.2%, P<0.01). The carriers of rare C allele had higher TG levels as compared with carriers of common allele in the three groups (P<0.01). Logistic regression models, which were adjusted for age, gender, blood pressure, BMI, FBS, smoking, LDL-C and HDL-C, revealed that patients carrying the apoA5 −1131C allele and CC homozygotes were at high risk for T2DMCI. It was concluded that the apoA5 −1131C allele variant is an independent genetic risk factor for T2DMCI.